You just read:

Neurelis Files New Drug Application With The FDA For VALTOCO™ Nasal Spray, An Investigational Treatment For Pediatric, Adolescent And Adult Epilepsy Patients

News provided by

Neurelis, Inc.

Sep 25, 2018, 09:00 ET